These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 2209491

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clomipramine for obsessive-compulsive disorder.
    Feinberg M.
    Am Fam Physician; 1991 May; 43(5):1735-8. PubMed ID: 2021107
    [Abstract] [Full Text] [Related]

  • 25. Clinical features associated with treatment response in obsessive-compulsive disorder.
    Shavitt RG, Belotto C, Curi M, Hounie AG, Rosário-Campos MC, Diniz JB, Ferrão YA, Pato MT, Miguel EC.
    Compr Psychiatry; 2006 May; 47(4):276-81. PubMed ID: 16769302
    [Abstract] [Full Text] [Related]

  • 26. Obsessive-compulsive disorder.
    George MS.
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intravenous anti-obsessive agents: a review.
    Ravindran LN, Jung SM, Ravindran AV.
    J Psychopharmacol; 2010 Mar; 24(3):287-96. PubMed ID: 18801828
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 30. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M, Jones B, Olson S, Perel JM.
    Psychopharmacol Bull; 1990 Apr; 26(1):119-22. PubMed ID: 2371366
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Treating the anxiety: therapeutic options in obsessive compulsive disorder.
    Greist JH.
    J Clin Psychiatry; 1990 Nov; 51 Suppl():29-34. PubMed ID: 2146255
    [Abstract] [Full Text] [Related]

  • 34. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF, Correa H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract] [Full Text] [Related]

  • 35. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug 01; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X.
    Am J Psychiatry; 2005 Jan 01; 162(1):151-61. PubMed ID: 15625214
    [Abstract] [Full Text] [Related]

  • 38. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M.
    Arch Gen Psychiatry; 1985 Oct 01; 42(10):977-83. PubMed ID: 3899048
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.